VE
Vera Therapeutics
VERA·NASDAQS San Francisco CAFounded 201480 employees
Mid CapbiotechPublicNephrology
Platform: Anti-APRIL IgAN
Market Cap
$2B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (VERA)
Loading VERA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talatuximab | VER-138 | Phase 1/2 | 2 | SHP2 | FabryPAH | ||
| Niraderotide | VER-4521 | Phase 2/3 | 2 | CDK2 | Parkinson'sMG |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)